Atlantis Health

What Atlantis Health does

Atlantis Health is a private, New Zealand-headquartered behaviour change and patient engagement company founded in 1996. The firm designs, develops and delivers tailored multichannel patient engagement solutions for pharmaceutical, biotech and healthcare organisations, with a stated mission of improving medication adherence and health behaviours among patients managing long-term conditions. Its offerings span four modules aligned to the patient journey: Discovery and Pre-Diagnosis Activation, Diagnosis Acceptance, Treatment Initiation and Access, and Illness Self-Management Empowerment, all powered by a multichannel digital engagement platform that combines health psychology, behavioural science and co-design with patients and providers.

The underlying technology is grounded in evidence-based health psychology rather than AI or machine learning; the platform leverages data-driven personalization and multichannel delivery (digital and human touchpoints) to operationalize behaviour change interventions. Atlantis Health's approach rests on three pillars: applying health psychology and behavioural science, co-designing experiences with patients and HCPs, and deploying data-driven digital platforms for multichannel engagement. The firm cites published research, case studies (e.g., integrated patient support for psoriatic disease, global oncology patient study) and a behavioural science leadership team (Dr. Kate Perry, Group Behavioural Science Director) as evidence of its scientific depth.

Atlantis Health operates a B2B enterprise go-to-market model, engaging directly with 11 of the world's largest pharmaceutical companies — AbbVie, Bayer, GSK, Janssen, Lilly, Novartis, Roche, Sanofi, Takeda, UCB and Merck — as well as NZ Blood. Solutions are delivered at both global and local levels across 30+ countries. Revenue is generated through professional services contracts (project or retainer-based engagements) tailored to each client's therapy area and brand objectives; pricing is not publicly disclosed. Cumulative disclosed funding is approximately $46M across rounds in 2010 ($14.27M) and 2014 ($32M, led by Callaghan Innovation), after which the 251-500 employee company appears to have continued operating and scaling without subsequent disclosed external capital raises.

Name

Atlantis Health

Legal name

Atlantis Health

Website

https://atlantishealth.com

Company type

Private

Founded year

1996

Operating status

Operating

Headcount range

51–100 employees

Short description

Atlantis Health is a New Zealand-based, private behaviour change company that designs and delivers multichannel patient engagement solutions for pharmaceutical, biotech and healthcare organisations across 30+ countries, with a focus on improving medication adherence and health outcomes for patients with long-term conditions.

Ownership category

akta.pro rank

Headquarters

HQ city

Summit

HQ country

United States

HQ region

North America

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales

Revenue model

1. Patient Engagement Solutions: Provides tailored, multichannel patient engagement solutions to pharmaceutical, biotech and healthcare organisations. Services span across the patient health journey from pre-diagnosis through illness self-management. Revenue likely derived from service contracts with pharmaceutical and healthcare clients, potentially on a project or retainer basis.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Core offering

Atlantis Health designs and delivers tailored, multichannel patient engagement and behaviour change solutions for pharmaceutical, biotech and healthcare organisations. Using health psychology and behavioural science, the company improves medication adherence and health behaviours of people managing long-term health conditions across the patient journey, from pre-diagnosis through diagnosis acceptance, treatment initiation, and illness self-management.

Product overview

Atlantis Health offers a unified patient engagement platform designed for pharmaceutical, biotech and healthcare organizations. The platform combines behavioral science, co-design with patients and providers, and data-driven digital engagement tools. The core offering includes modules across four stages of the patient journey: Discovery and Pre-Diagnosis Activation, Diagnosis Acceptance, Treatment Initiation and Access, and Illness Self-Management Empowerment, all powered by a multichannel engagement platform that delivers personalized behavior change interventions.

Differentiator

Problem solved

Functional benefit

Products and services

• Patient Engagement Solutions Platform

Quantifiable outcome

• Engaged patients show 8-21% lower healthcare costs
• +1 more outcomes

Named customers12 records

Segments2 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Twelve partnerships are on record, tiered core.

• AbbViecoreStrategic or Co-development PartnerPharmaceutical partner collaborating with Atlantis Health on patient engagement and behaviour change solutions for long-term health conditions. AbbVie is listed among the world's leading pharmaceutical companies served by Atlantis Health.
• BayercoreStrategic or Co-development PartnerPharmaceutical partner working with Atlantis Health on patient engagement solutions. Listed as one of the leading pharmaceutical clients served across their global operations.
• GSKcoreStrategic or Co-development PartnerPharmaceutical partner collaborating with Atlantis Health on patient engagement and behaviour change solutions for patients managing long-term conditions.
• JanssencoreStrategic or Co-development PartnerPharmaceutical partner (Janssen Pharmaceutical Companies of Johnson & Johnson) engaged with Atlantis Health for patient engagement solutions.
• LillycoreStrategic or Co-development PartnerEli Lilly and Company partner working with Atlantis Health on patient engagement solutions for long-term health conditions.
• NovartiscoreStrategic or Co-development PartnerPharmaceutical partner collaborating with Atlantis Health on patient engagement and behaviour change solutions.
• RochecoreStrategic or Co-development PartnerPharmaceutical partner working with Atlantis Health on patient engagement solutions across global operations.
• SanoficoreStrategic or Co-development PartnerPharmaceutical partner engaged with Atlantis Health for patient engagement and behaviour change solutions.
• TakedacoreStrategic or Co-development PartnerPharmaceutical partner collaborating with Atlantis Health on patient engagement solutions.
• UCBcoreStrategic or Co-development PartnerPharmaceutical partner working with Atlantis Health on patient engagement and behaviour change solutions.
• MerckcoreStrategic or Co-development PartnerPharmaceutical partner (Merck KGaA / Merck & Co.) engaged with Atlantis Health for patient engagement solutions.
• NZ BloodcoreStrategic or Co-development PartnerHealthcare organization partner collaborating with Atlantis Health on patient engagement solutions in New Zealand.

Scale indicators2 records

Recent moves6 records

Expansion highlights5 records

Market position

Weaknesses1 record

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/atlantis-health
• Xx.com/AtlantisHtweets

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds2 records

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Atlantis Health